HOME >> BIOLOGY >> NEWS
American Heart Association Announces Top 10 Research Advances For 1998 -- Gene Therapy Among The List

DALLAS, Dec 30 -- Gene therapy to grow new blood vessels to the heart, strong confirmation that "superaspirin" IIb/IIIa receptor blocker drugs prevent blood clots, the importance of inflammation throughout the blood in cardiovascular disease, and a study on the deadly effects of smoking fewer than 10 cigarettes a day are among the top 10 research advances in heart disease and stroke during 1998, says Valentin Fuster, M.D., Ph.D., president of the American Heart Association. The list, first created in 1996, recognizes achievements in basic and clinical research that may have the greatest impact in improving the prevention and treatment of cardiovascular disease, the nation's No.1 killer.

1. Gene therapy to create a "natural" bypass to circumvent plaque obstructions in the heart's blood vessels
In the next century many people with heart disease may be routinely treated with a genetically engineered therapy that induces the growth of new blood vessels to and from the heart. These new vessels would help restore blood flow to the hearts of people whose arteries are obstructed by fat-laden plaque. By impeding blood flow, these fatty obstructions can cause severe chest pain, heart attacks and strokes. Gene therapy may become an adjunct to other therapies for heart disease, which now include low saturated fat diets, exercise, smoking cessation, and, if appropriate, medications such as cholesterol-lowering drugs and the surgical procedures of cardiac bypass surgery and angioplasty. Gene therapy to create natural bypasses is described in research published this year in Circulation: Journal of the American Heart Association. This research was also presented at the 71st Scientific Sessions, AHA's largest medical conference, in November. "At the American Heart Association's meeting in 1997, scientists described very preliminary research findings that unlocked the door to using gene therapy for heart disease," says Fuster. "This past year, researchers op
'"/>

Contact: Cathy Yarbrough
cathyy@heart.org
214-706-1340
American Heart Association
30-Dec-1998


Page: 1 2 3 4 5 6 7 8 9 10

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. The American Phytopathological Society announces 2004 awards
3. Tips from the Journals of the American Society for Microbiology
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
6. Tips from the journals of the American Society for Microbiology
7. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
8. More aggressive breast cancer tumors found in African American women
9. American Society of Mammalogists honors CI president Russell Mittermeier with Aldo Leopold award
10. Tips from the Journals of the American Society for Microbiology
11. Most Americans not sure about the sources of high cholesterol

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... ... September 30, 2019 , ... ... organization focused on molecular manufacturing and other transformative technologies, announced the 2018 ... College graduate or undergraduate student whose work is considered most notable in ...
(Date:9/24/2019)... ... September 23, 2019 , ... ... Cambridge, MA, announce today that Holotype HLA and other Omixon products will be ... the American Society for Histocompatibility and Immunogenetics (ASHI) in Pittsburgh, PA. ...
(Date:9/17/2019)... ... 17, 2019 , ... VISTAAR released ADVISORY Playbooks to help small ... / 2nd opinion to their internal strategies they formed for developing or launching new ... new markets, or planning to change their product elements and want to know the ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 10, 2019 , ... VirTrial today ... centers in Europe. All Pratia research centers have completed VirTrial’s Virtual Trial Capable ... certified as Virtual Trial Capable and prepared to conduct decentralized clinical trials (DCT). ...
(Date:10/8/2019)... ... ... Today, Massachusetts stem cell biotechnology company Asymmetrex announces the recent patenting in ... in the U.S. in 2017, the new patent covers the company’s unique technology for ... in the U.S. as the AlphaSTEM Test™. The new patent will support marketing ...
(Date:10/3/2019)... ... 2019 , ... Today marked the official launch of ... outsourcing success by cultivating radical improvements in leadership, staff, and broader project team ... phaseUP™ brings clients deep, broad and unique expertise in the intricacies of drug ...
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, Inc., the world's ... it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. Now home ... the company's continuous commitment to quality research and service offerings. , ...
Breaking Biology Technology:
Cached News: